5 recruiting. 5 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Recruiting 5 |
| Phase 2 | 3 | Recruiting 3 |
Follow Communication Disorders: new trials by email Literature Review of Communication Disorders trials Research Report on Communication Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dopamine and Sensorimotor Function in Stuttering Aripiprazole 10 MG, Placebo - Stuttering, Adult | Phase 1 | Recruiting | University of California, San Francisco | 25 | 2025-09-30 | 2026-08-19 |
| A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound Clemastine Fumarate Combined With Engineered Sound, Clemastine Fumarate Combined With Pink Noise, Placebo Drug With Engineered Sound - Central Auditory Processing Disorder, Hearing Impaired (Partially) | Phase 1 / Phase 2 | Recruiting | University of Colorado, Denver | 344 | 2025-03-31 | 2026-04-30 |
| Treatment Targets in Spanish and English Bilingual Speech Intervention Speech Intervention - Speech Sound Disorder | Phase 1 | Recruiting | Philip Combiths | 16 | 2024-05-08 | 2025-09-05 |
| Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders Speech Motor Chaining - Speech Sound Disorder | Phase 1 / Phase 2 | Recruiting | Syracuse University | 84 | 2023-10-26 | 2026-01-13 |
| A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN) Intrathalamic AAV.PGRN administration, Intrathalamic AVB-101 - Frontotemporal Dementia, FTD | Phase 1 / Phase 2 | Recruiting | AviadoBio Ltd | 18 | 2023-08-30 | 2026-08-13 |
Speech Sound Disorder (2) · Aphasia, Primary Progressive (1) · Auditory Diseases, Central (1) · Dementia (1) · Frontotemporal Dementia (1) · Hearing Disorders (1) · Hearing Loss (1) · Hearing Loss, Hidden (1) · Hearing Loss, Noise-Induced (1) · Hearing Loss, Sensorineural (1) · Language Development Disorders (1) · Presbycusis (1) · Speech (1) · Stuttering (1)
Language Disorders (3) · Mental Disorders (3) · Nervous System Diseases (3) · Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Neurodevelopmental Disorders (2) · Speech Disorders (2) · Aphasia (1) · Behavior (1) · Communication (1)
Aripiprazole (1) · Clemastine (1) · Placebo Effect (1)
AviadoBio Ltd (1) · Philip Combiths (1) · Syracuse University (1) · University of California, San Francisco (1) · University of Colorado, Denver (1)
United States (5) · Belgium (1) · Canada (1) · Italy (1) · Netherlands (1) · Poland (1) · Spain (1) · Sweden (1) · United Kingdom (1)
Achim Klug, PhD (1) · John Houde, PhD (1) · Jonathan Preston, PhD (1) · Ludo Max, PhD (1) · Samuel A Budoff, PhD, MS (1) · Srikantan Nagarajan, PhD (1)
2023 (1), R01DC020959 (1), R21DC021249 (1), R21DC021557 (1)